Amplification and Overexpression of CTTN (EMS1) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance

Cancer Research - United States
doi 10.1158/0008-5472.can-06-1484
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Suppression of Anoikis by SKP2 Amplification and Overexpression Promotes Metastasis of Esophageal Squamous Cell Carcinoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2009English

Rad9 Protein Contributes to Prostate Tumor Progression by Promoting Cell Migration and Anoikis Resistance

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Case Report: Scleral Metastasis of Esophageal Squamous Cell Carcinoma

Ophthalmology and Therapy
Ophthalmology
2018English

Contribution of Dysregulated circRNA_100876 to Proliferation and Metastasis of Esophageal Squamous Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2018English

Radiation-Resistance Increased by Overexpression of microRNA-21 and Inhibition of Its Target PTEN in Esophageal Squamous Cell Carcinoma

Journal of International Medical Research
BiochemistryMedicineCell Biology
2020English

Overexpression of GPR39 Contributes to Malignant Development of Human Esophageal Squamous Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Esophageal Squamous Cell Papilloma, Suspected of Squamous Cell Carcinoma.

Internal Medicine
Internal MedicineMedicine
1993English

Human Lymphatic Endothelial Cells Contribute to Epithelial Ovarian Carcinoma Metastasis by Promoting Lymphangiogenesis and Tumour Cell Invasion

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

circGSK3β Promotes Metastasis in Esophageal Squamous Cell Carcinoma by Augmenting Β-Catenin Signaling

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy